Meta AnalysisID 1938

对乙酰氨基酚(扑热息痛)联用或不联用可待因或双氢可待因治疗成人神经病理性疼痛[Cochrane方案]

CRD42016045967

To assess the analgesic efficacy and adverse events of paracetamol with or without codeine or dihydrocodeine for chronic neuropathic pain in adults.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
1938
Evidence Id
10496
Core Evidence Id
10496
Source Meta Analysis Id
1881
Herb2 Meta Analysis Id
HBMA001881
Crd Id
CRD42016045967
Title
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults [Cochrane Protocol]
Review Question
To assess the analgesic efficacy and adverse events of paracetamol with or without codeine or dihydrocodeine for chronic neuropathic pain in adults.
Study Type Included
We will include randomised controlled trials (RCTs) with double-blind assessment of participant outcomes following two weeks or more of treatment, although the emphasis of the review will be on studies with a duration of eight weeks or longer. We require full journal publication, with the exception of online clinical trial results summaries of otherwise unpublished clinical trials and abstracts with sufficient data for analysis. We will not include short abstracts (usually meeting reports). We will exclude studies that are non-randomised, studies of experimental pain, case reports, and clinical observations.
Condition Being Studied
The Cochrane Pain, Palliative and Supportive Care Group
Participant
Studies will include adults aged 18 years and above with one or more chronic neuropathic pain condition including (but not limited to):<ol> cancer-related neuropathy; central neuropathic pain; complex regional pain syndrome (CRPS) Type II; human immunodeficiency virus (HIV) neuropathy; painful diabetic neuropathy (PDN); phantom limb pain; postherpetic neuralgia (PHN); postoperative or traumatic neuropathic pain; spinal cord injury; trigeminal neuralgia.</ol> Where we include studies of participants with more than one type of neuropathic pain, we will analyse results according to the primary condition.
Animal
Human Disease Modelled
Intervention
Oral paracetamol with or without codeine or dihydrocodeine, at any dose, administered for the relief of neuropathic pain and compared with placebo or any active comparator.
Comparator Control
Oral paracetamol with or without codeine or dihydrocodeine, at any dose, administered for the relief of neuropathic pain and compared with placebo or any active comparator.
Main Outcome
<ol> Participant-reported pain relief of 30% or greater. Participant-reported pain relief of 50% or greater. PGIC much or very much improved. PGIC very much improved. </ol>
Outcome Measure
Additional Outcome
<ol> Any pain-related outcome indicating some improvement. Withdrawals due to lack of efficacy, adverse events, and for any cause. Participants experiencing any adverse event. Participants experiencing any serious adverse event. Serious adverse events typically include any untoward medical occurrence or effect that at any dose results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, is an 'important medical event' that may jeopardise the patient, or may require an intervention to prevent one of the above characteristics or consequences. Specific adverse events, particularly somnolence and dizziness. </ol>
Study Method
Intervention, Systematic review
Keyword
Acetaminophen; Adult; Analgesics, Non-Narcotic; Codeine; Drug Therapy; Drug Therapy, Combination; Humans; Neuralgia; Pain; Pain Management; Treatment Outcome
Contact
R Andrew Moore [email protected]
Organisational Affiliation
The Cochrane Collaboration http://www.cochrane.org/
Funding Source
The National Institute for Health Research (NIHR), Oxford Pain Relief Trust
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
England
Review Stage
Review Ongoing
First Submission Date
Registration Date
2016-08-15
Anticipated Start Date
2016-06-15
Anticipated Completion Date
2016-12-31
Title Cn
对乙酰氨基酚(扑热息痛)联用或不联用可待因或双氢可待因治疗成人神经病理性疼痛[Cochrane方案]
Title En
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults [Cochrane Protocol]
Bilingual Status
complete